Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
Holding SRPT?
Track your performance easily

Sarepta Therapeutics (SRPT) Cash flow

2,989 Followers

Sarepta Therapeutics Cash Flow

SRPT's free cash flow for Q2 2024 was $-14.22M. For the 2024 fiscal year, SRPT's free cash flow was decreased by $-495.99M and operating cash flow was $14.94M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -396.50M$ -500.99M$ 9.65M$ -443.17M$ 107.47M$ -456.46M
Investing Cash Flow
$ -154.66M$ -165.80M$ -1.05B$ 495.41M$ -121.72M$ 286.73M
Financing Cash Flow
$ 79.41M$ 125.00M$ 232.51M$ 561.57M$ 682.32M$ 642.55M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 1.85B$ 444.01M$ 9.65M$ 2.13B$ 1.51B$ 843.64M
Income Tax Paid Supplemental Data
$ 23.07M$ 15.08M$ 1.70M$ 583.00K$ 2.51M$ 933.00K
Interest Paid Supplemental Data
$ 16.09M$ 15.92M$ 44.42M$ 55.95M$ 34.42M$ 8.55M
Issuance Of Capital Stock
----$ 312.05M$ 365.35M
Issuance Of Debt
--$ 576.68M-$ 291.15M$ 245.63M
Repayment Of Debt
--$ -550.72M-$ 0.00$ 0.00
Free Cash Flow
$ -528.06M$ -486.34M$ 9.65M$ -379.66M$ 25.26M$ -516.09M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Sarepta Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis